Skrzynka do zadań specjalnych

Skrzynka : konon, Subskrybuj: RSS, Alias:

Same Plusy!

  • nie wymaga rejestracji, aktywacji, nie wysyła SPAMU!
  • Nie dostaniesz spamu na swoją prywatną skrzynkę E-mail
  • Nigdy nie usuniemy Twojej skrzynki i będziesz mógł przypomnieć sobie hasło do innej strony kiedy chcesz
  • Używając aliasów nikt inny nie będzie wiedział jakiego użyłeś loginu do naszego serwisu
  • Nowe! W dowolnym formularzu rejestracyjnym użyj adresu rozpoczynającego się na a_ (np. a Twój link aktywacyjny zostanie automatycznie kliknięty.

Second week of AdvaMed MedTech Conference begins

<< Starsza wiadomość Nowsza wiadomość >>

Treść wiadomości:

AdvaMed SmartBrief
Thermo Fisher boosts lab plastics production for COVID-19 | New president of global extremities appointed by Orthofix | NIH grants $2.3M to Quadrant Biosciences for concussion test
Created for |  Web Version
September 16, 2020
ADVAMED SmartBrief
News for medical technology professionalsSIGN UP ⋅   SHARE
Top Story
The second week of AdvaMed's virtual The MedTech Conference is set to begin today, and the conference will cover themes including cybersecurity, the EU MDR, inspections and AI. Future annual conferences are likely to offer a combination of virtual and in-person sessions, said AdvaMed Chair and Stryker CEO Kevin Lobo.
Full Story: Medical Design & Outsourcing (9/15) 
LinkedIn Twitter Facebook Email
Business & Market Trends
Thermo Fisher Scientific is investing approximately $140 million to scale up production of laboratory plastics disposables to meet demand for manufacturing and development of therapies, vaccines and for COVID-19 testing worldwide.
Full Story: Medical Design & Outsourcing (9/15) 
LinkedIn Twitter Facebook Email
Paul Gonsalves has been chosen to serve as president of global extremities at Orthofix. Gonsalves has previously served as Integra Lifesciences' chief commercial officer.
Full Story: Becker's Spine Review (9/14) 
LinkedIn Twitter Facebook Email
The National Institutes of Health granted $2.3 million to Quadrant Biosciences to aid in the development of a saliva-based microRNA diagnostic test for concussions in adolescents and children.
Full Story: 360Dx (tiered subscription model) (9/15) 
LinkedIn Twitter Facebook Email
Is Your Supply Chain Up to the Task?
Gartner has identified the most prevalent obstacles and inefficiencies life sciences manufacturers face with their supply chain. Download the report today and find out where you stand.
Science & Health
Researchers found that an artificial intelligence-guided peer review project identified missed lung cancer nodules in 0.6% of CT exams over nine months, enabling a nearly eightfold improvement in discrepancy detection, compared with the traditional peer review approach. The findings were presented at the Conference on Machine Intelligence in Medical Imaging.
Full Story: AuntMinnie (free registration) (9/15) 
LinkedIn Twitter Facebook Email
Emerging Technologies
Researchers from Japan have developed a painless diagnostic tool made of porous microneedles and paper-based sensors that can potentially be used to screen for conditions like prediabetes. The patches are disposable, biodegradable and biocompatible, and they can also be used without medical expertise or training, according to a study in the journal Medical Devices & Sensors.
Full Story: Medical Dialogues (9/15) 
LinkedIn Twitter Facebook Email
Government & Regulatory
The FDA has given 510(k) clearance to Varian Medical Systems for its Eclipse v16.1 treatment planning software that allows dosimetrists to make more precise plans while they perform proton therapy by improving the visibility of soft tissue and providing more accurate information on tissue density.
Full Story: MassDevice (Boston) (9/15) 
LinkedIn Twitter Facebook Email
European regulators have given CE mark approval to Eurobio Scientific for its EBX 042 FluCoSyn test that can identify influenza A and B, SARS-CoV-2 and respiratory syncytial virus.
Full Story: GenomeWeb Daily News (free registration) (9/15) 
LinkedIn Twitter Facebook Email
The FDA has given 510(k) clearance to ControlRad for its ControlRad Trace on OEC 9900 Mobile C-arms to reduce radiation during fluoroscopically guided procedures.
Full Story: MassDevice (Boston) (9/15) 
LinkedIn Twitter Facebook Email
European regulators have given CE mark approval to Fibralign for its BioBridge collagen matrix, a biodegradable surgical mesh used in lymphedema treatment. The device has also received 510(k) clearance from the FDA for repairing and reinforcing soft tissue.
Full Story: FDAnews (9/16) 
LinkedIn Twitter Facebook Email
AdvaMed Events and Education
Join us this fall for a new conference experience -- The Virtual MedTech Conference! We have reimagined how to bring you valuable opportunities to learn, network and connect in today's world. Expect the same high-quality education, world-class speakers and valuable business development in a dynamic and immersive virtual format. In addition, you have the unique opportunity to experience more of the conference with on demand content and partnering from Sept. 8 to Oct. 23, and livestreamed sessions taking place from October 5-7. Registration is now open -- secure your pass today. Learn more.
LinkedIn Twitter Facebook Email
With our member companies on the front lines of the fight against the COVID-19 pandemic, AdvaMed is working diligently to address the medtech industry's needs and provide resources that support you and your businesses during this challenging time. To better support you, we have launched a new COVID-19 Resource Center to provide important information to companies about the federal response to COVID-19, best practices and other valuable resources. Learn more.
LinkedIn Twitter Facebook Email
About AdvaMed | Join | Courses | Events | Newsroom
  Medical Device Regulatory Expert - Digital Health
  Medical Device Regulatory Expert
View More Listings | Post a Job
Sharing AdvaMed SmartBrief with your network keeps the quality of content high and these newsletters free.
Help Spread the Word
W celu usunięcia maila wpisz ten tekst: 5539f236
Aby zaznaczyć ten mail jako spam wpisz ten tekst: 5539f236

<< Starsza wiadomość Nowsza wiadomość >>
Ważne: nasze strony wykorzystują pliki cookies.

Bez tych plików serwis nie będzie działał poprawnie. W każdej chwili, w programie służącym do obsługi internetu, można zmienić ustawienia dotyczące cookies. Korzystanie z naszego serwisu bez zmiany ustawień oznacza, że będą one zapisane w pamięci urządzenia. Więcej informacji w Polityce prywatności.

Zapoznałem się z informacją